• Develop and execute a dynamic territory business plan targeting geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and multi-disciplinary skeletal dysplasia clinic teams to meet and exceed sales goals. • Demonstrate deep expertise in Infigratinib, achondroplasia, and the broader skeletal dysplasia landscape; engage HCPs in clinically relevant, compliant discussions. • Use sales and target data to identify growth opportunities and address territory challenges proactively. • Anticipates potential business challenges, adjusts priorities as needed, demonstrates flexibility, and develops solutions to address challenges. • Partners compliantly with Field Medical Directors, Field Reimbursement Managers, Family Account Managers, and the HUB to maximize customer and family satisfaction. • Build and maintain relationships with KOLs in partnership with Marketing and Medical Affairs to expand advocacy for Infigratinib and BridgeBio. • Operate with an “One Bridge” mindset—collaborating across the organization to execute company initiatives and represent BridgeBio with integrity. • Maintains an exceptional level of proficiency in selling skills, clinical, market and product knowledge and the business environment of the territory. • Ensure all activities comply with applicable regulations, company policies, and Pharma guidelines.

• Develop and execute a dynamic territory business plan targeting geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and multi-disciplinary skeletal dysplasia clinic teams to meet and exceed sales goals. • Demonstrate deep expertise in Infigratinib, achondroplasia, and the broader skeletal dysplasia landscape; engage HCPs in clinically relevant, compliant discussions. • Use sales and target data to identify growth opportunities and address territory challenges proactively. • Anticipates potential business challenges, adjusts priorities as needed, demonstrates flexibility, and develops solutions to address challenges. • Partners compliantly with Field Medical Directors, Field Reimbursement Managers, Family Account Managers, and the HUB to maximize customer and family satisfaction. • Build and maintain relationships with KOLs in partnership with Marketing and Medical Affairs to expand advocacy for Infigratinib and BridgeBio. • Operate with an “One Bridge” mindset—collaborating across the organization to execute company initiatives and represent BridgeBio with integrity. • Maintains an exceptional level of proficiency in selling skills, clinical, market and product knowledge and the business environment of the territory. • Ensure all activities comply with applicable regulations, company policies, and Pharma guidelines.

• Develop and execute a dynamic territory business plan targeting geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and multi-disciplinary skeletal dysplasia clinic teams to meet and exceed sales goals. • Demonstrate deep expertise in Infigratinib, achondroplasia, and the broader skeletal dysplasia landscape; engage HCPs in clinically relevant, compliant discussions. • Use sales and target data to identify growth opportunities and address territory challenges proactively. • Anticipates potential business challenges, adjusts priorities as needed, demonstrates flexibility, and develops solutions to address challenges. • Partners compliantly with Field Medical Directors, Field Reimbursement Managers, Family Account Managers, and the HUB to maximize customer and family satisfaction. • Build and maintain relationships with KOLs in partnership with Marketing and Medical Affairs to expand advocacy for Infigratinib and BridgeBio. • Operate with an “One Bridge” mindset—collaborating across the organization to execute company initiatives and represent BridgeBio with integrity. • Maintains an exceptional level of proficiency in selling skills, clinical, market and product knowledge and the business environment of the territory. • Ensure all activities comply with applicable regulations, company policies, and Pharma guidelines.

• Develop and execute a dynamic territory business plan targeting geneticists, pediatric endocrinologists, orthopedic specialists, pediatricians, and multi-disciplinary skeletal dysplasia clinic teams to meet and exceed sales goals. • Demonstrate deep expertise in Infigratinib, achondroplasia, and the broader skeletal dysplasia landscape; engage HCPs in clinically relevant, compliant discussions. • Use sales and target data to identify growth opportunities and address territory challenges proactively. • Anticipates potential business challenges, adjusts priorities as needed, demonstrates flexibility, and develops solutions to address challenges. • Partners compliantly with Field Medical Directors, Field Reimbursement Managers, Family Account Managers, and the HUB to maximize customer and family satisfaction. • Build and maintain relationships with KOLs in partnership with Marketing and Medical Affairs to expand advocacy for Infigratinib and BridgeBio. • Operate with an “One Bridge” mindset—collaborating across the organization to execute company initiatives and represent BridgeBio with integrity. • Maintains an exceptional level of proficiency in selling skills, clinical, market and product knowledge and the business environment of the territory. • Ensure all activities comply with applicable regulations, company policies, and Pharma guidelines.